Biotransformation of finasteride by Ocimum sanctum L., and tyrosinase inhibitory activity of transformed metabolites: experimental and computational insights

Steroids. 2014 Dec:92:20-4. doi: 10.1016/j.steroids.2014.07.007. Epub 2014 Aug 23.

Abstract

Transformation of Finasteride (I) by cell suspension cultures of Ocimum sanctum L. was investigated. Fermentation of compound (I) with O. sanctum afforded three oxidized derivatives, 16β-hydroxyfinasteride (II), 11α-hydroxyfinasteride (III) and 15β-hydroxyfinasteride (IV). Among these metabolites, compound (II) was a new metabolite. Compound (I) and its derivatives were studied for their tyrosinase inhibition assay. All test compounds exhibited significant activity compared to standard drug kojic acid, with compound IV being the most potent member with an IC50 of 1.87μM. Molecular docking revealed significant molecular interactions behind the potent tyrosinase inhibitory activity of the tested compounds.

Keywords: 11α-Hydroxyfinasteride; 15β-Hydroxyfinasteride; 16β-Hydroxyfinasteride; Finasteride; Ocimum sanctum L.; Tyrosinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Inhibitors / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Finasteride / metabolism*
  • Finasteride / pharmacology*
  • Monophenol Monooxygenase / antagonists & inhibitors*
  • Ocimum / metabolism*

Substances

  • Enzyme Inhibitors
  • Finasteride
  • Monophenol Monooxygenase